COST-EFFECTIVENESS OF QUADRIVALENT HPV VACCINATION IN FINLAND

被引：0
|
作者：
Vaananen, J. J. P. [1 ]
Herse, F. [1 ]
Korkeamaki, J. [2 ]
Parvinen, P. M. T. [1 ]
Remy, O. [3 ]
机构：
[1] Nord Healthcare Grp, Helsinki, Finland
[2] Sanofi Pasteur MSD Oy, Helsinki, Finland
[3] Sanofi Pasteur MSD, Lyon, France
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66455-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A431 / A431
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
    Szucs, Thomas D.
    Largeron, Nathalie
    Dedes, Konstantin J.
    Rafia, Rachid
    Benard, Steve
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (05) : 1473 - 1483
  • [42] Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada
    De Wals, Philippe
    Zhou, Zhou
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (07) : E203 - E207
  • [43] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINATION PROGRAM FOR THE ELDERLY AGED 65 YEARS OR OLDER IN TAIWAN
    Yang, M. C.
    Tan, C. H.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A276 - A276
  • [44] Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program
    Zeevat, Florian
    Crepey, Pascal
    Dolk, F. Christiaan K.
    Postma, Arjan J.
    Breeveld-Dwarkasing, Vidya N. A.
    Postma, Maarten J.
    [J]. VALUE IN HEALTH, 2021, 24 (01) : 3 - 10
  • [45] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINATION IN THE DUTCH NATIONAL INFLUENZA PREVENTION PROGRAM
    Zeevat, F.
    Crepey, P.
    Dolk, C.
    Postma, A. J.
    Breeveld-Dwarkasing, V. N. A.
    Postma, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S647 - S647
  • [46] Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis
    Rosettie, Katherine L.
    Joffe, Jonah N.
    Sparks, Gianna W.
    Aravkin, Aleksandr
    Chen, Shirley
    Compton, Kelly
    Ewald, Samuel B.
    Mathew, Edwin B.
    Michael, Danielle
    Velandia, Paola Pedroza
    Miller-Petrie, Molly B.
    Stafford, Lauryn
    Zheng, Peng
    Weaver, Marcia R.
    Murray, Christopher J. L.
    [J]. PLOS ONE, 2021, 16 (12):
  • [47] Cost-Effectiveness of Varicella Vaccination
    Yasri, Sora
    Wiwanitkit, Viroj
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2019, 10
  • [48] Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
    Joël Arthur Kiendrébéogo
    Annick Raissa O. Sidibe
    Ghislain Bertrand Compaoré
    Relwendé Nacanabo
    Orokia Sory
    Issa Ouédraogo
    Saira Nawaz
    Anne E Schuind
    Andrew Clark
    [J]. BMC Health Services Research, 23
  • [49] Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
    Samik Datta
    Joshua Pink
    Graham F. Medley
    Stavros Petrou
    Sophie Staniszewska
    Martin Underwood
    Pam Sonnenberg
    Matt J. Keeling
    [J]. BMC Infectious Diseases, 19
  • [50] Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study
    Mwenda, Valerian
    Jalang'o, Rose
    Miano, Christine
    Bor, Joan-Paula
    Nyangasi, Mary
    Mecca, Lucy
    Were, Vincent
    Kariithi, Edward
    Pecenka, Clint
    Schuind, Anne
    Abbas, Kaja
    Clark, Andrew
    [J]. VACCINE, 2023, 41 (29) : 4228 - 4238
12345